Regenxbio Company Insiders

Regenxbio's latest congressional trading

Regenxbio Management Team Effectiveness

The company has return on total asset (ROA) of (0.2603) % which means that it has lost $0.2603 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7187) %, meaning that it created substantial loss on money invested by shareholders. Regenxbio's management efficiency ratios could be used to measure how well Regenxbio manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.48 in 2024. Return On Capital Employed is likely to rise to -0.57 in 2024. At this time, Regenxbio's Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 8.4 M in 2024, whereas Total Assets are likely to drop slightly above 487 M in 2024. Common Stock Shares Outstanding is likely to drop to about 33.3 M in 2024. Net Loss is likely to rise to about (239.7 M) in 2024

Regenxbio Workforce Comparison

Regenxbio Profit Margins

The company has Profit Margin (PM) of (2.83) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.57.

Regenxbio Insider Trading History

Regenxbio Notable Stakeholders

The success or failure of an entity such as Regenxbio often depends on how effective the management is. Regenxbio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Regenxbio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Regenxbio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Regenxbio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Regenxbio. Check Regenxbio's Beneish M Score to see the likelihood of Regenxbio's management manipulating its earnings.

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.